258 related articles for article (PubMed ID: 29967250)
1. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
[No Abstract] [Full Text] [Related]
2. [Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
Hirsch D; Gaiser T
Pathologe; 2018 Dec; 39(Suppl 2):253-261. PubMed ID: 30229283
[TBL] [Abstract][Full Text] [Related]
3. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
Hirsch D; Hardt J; Sauer C; Heselmeyer-Hadded K; Witt SH; Kienle P; Ried T; Gaiser T
Mod Pathol; 2021 Jun; 34(6):1153-1166. PubMed ID: 33318582
[TBL] [Abstract][Full Text] [Related]
5. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
[TBL] [Abstract][Full Text] [Related]
6. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.
Lennerz JK; van der Sloot KWJ; Le LP; Batten JM; Han JY; Fan KC; Siegel CA; Srivastava A; Park DY; Chen JH; Sands BE; Korzenik JR; Odze RD; Dias-Santagata D; Borger DR; Khalili H; Iafrate AJ; Lauwers GY
Int J Colorectal Dis; 2016 May; 31(5):973-982. PubMed ID: 27026089
[TBL] [Abstract][Full Text] [Related]
8. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Histopathologic Features of Colorectal Adenocarcinoma in Crohn's Disease.
Galata C; Hirsch D; Reindl W; Post S; Kienle P; Boutros M; Gaiser T; Horisberger K
J Clin Gastroenterol; 2018 Aug; 52(7):635-640. PubMed ID: 28654553
[TBL] [Abstract][Full Text] [Related]
10. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.
Rapozo DC; Grinmann AB; Carvalho AT; de Souza HS; Soares-Lima SC; de Almeida Simão T; de Paiva D; Abby F; Albano RM; Pinto LF
Int J Colorectal Dis; 2009 Oct; 24(10):1141-8. PubMed ID: 19543899
[TBL] [Abstract][Full Text] [Related]
12. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.
Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF
Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493
[TBL] [Abstract][Full Text] [Related]
13. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
14. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary history of human colitis-associated colorectal cancer.
Baker AM; Cross W; Curtius K; Al Bakir I; Choi CR; Davis HL; Temko D; Biswas S; Martinez P; Williams MJ; Lindsay JO; Feakins R; Vega R; Hayes SJ; Tomlinson IPM; McDonald SAC; Moorghen M; Silver A; East JE; Wright NA; Wang LM; Rodriguez-Justo M; Jansen M; Hart AL; Leedham SJ; Graham TA
Gut; 2019 Jun; 68(6):985-995. PubMed ID: 29991641
[TBL] [Abstract][Full Text] [Related]
16. Histological differentiation between sporadic and colitis-associated intestinal cancer in a nationwide study: A propensity-score-matched analysis.
Uchino M; Ikeuchi H; Noguchi T; Okabayashi K; Futami K; Tanaka S; Ohge H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Kono T; Kobayashi H; Ajioka Y; Sugihara K; Ishihara S;
J Gastroenterol Hepatol; 2024 May; 39(5):893-901. PubMed ID: 38273469
[TBL] [Abstract][Full Text] [Related]
17. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
Bui VM; Mettling C; Jou J; Sun HS
BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
19. Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.
Din S; Wong K; Mueller MF; Oniscu A; Hewinson J; Black CJ; Miller ML; Jiménez-Sánchez A; Rabbie R; Rashid M; Satsangi J; Adams DJ; Arends MJ
Clin Cancer Res; 2018 Oct; 24(20):5133-5142. PubMed ID: 29950348
[No Abstract] [Full Text] [Related]
20. Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers.
Sugai T; Takahashi Y; Eizuka M; Sugimoto R; Fujita Y; Habano W; Otsuka K; Sasaki A; Yamamoto E; Matsumoto T; Suzuki H
Mol Carcinog; 2018 Mar; 57(3):451-461. PubMed ID: 29230882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
